NCT05534646: Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer |
|
|
| Recruiting | 2 | 100 | US | Apalutamide, Carotuximab | Edwin Posadas, MD, Enviro Therapeutics, Inc. | Castration-resistant Prostate Cancer | 01/27 | 01/27 | | |
NCT01757652: Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma |
|
|
| Recruiting | 2 | 32 | US | anti-endoglin monoclonal antibody TRC105, TRC105, pharmacological study, pharmacological studies, laboratory biomarker analysis, quality-of-life assessment, quality of life assessment | National Cancer Institute (NCI) | Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor | 01/00 | | | |
NCT02520063: Combination of Letrozole, Everolimus and TRC105 in Postmenopausal Women With Hormone-Receptor Positive and Her2 Negative Breast Cancer |
|
|
| Completed | 1/2 | 15 | US | Letrozole, Femara, Everolimus, Afinitor, TRC105 | University of Alabama at Birmingham, Novartis Pharmaceuticals, Tracon Pharmaceuticals Inc. | Breast Cancer | 12/22 | 12/22 | | |
